# Allergan Breast Implant Lymphoma Lawsuit
THE FDA HAS RECALLED ALLERGAN TEXTURED BREAST IMPLANTS DUE TO BIA-ALCL RISK.
Yep, you read that right. R-E-C-A-L-L. Even though the FDA ruled earlier this year to keep the implants on the market, that all changed in July 2019 when new data made it clear: Allergan’s BIOCELL breast implants (the kind with the textured surface) have been linked to a disproportionate amount of Breast Implant Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) diagnoses. The FDA’s decision follows similar actions taken in France, Australia and Canada.
In the new study, the FDA found a total of 573 cases of BIA-ALCL across the globe, including 33 deaths, a significant increase since the last update in March 2019. Of the 573 reported cases, more than 80% are linked to the Allergan breast implants. The same study also found that the risk of BIA-ALCL was approximately six times higher with Allergan’s textured implants than with other manufacturers’ textured implant products sold in the U.S.
Per the FDA’s request, Allergan is moving forward with a voluntary recall of the company’s BIOCELL textured breast implants products, including:
- Natrelle Saline-Filled breast implants
- Natrelle Silicone-Filled breast implants
- Natrelle Inspira Silicone-Filled breast implants
- Natrelle 410 Highly Cohesive Anatomically Shaped Silicone-Filled breast implants
It’s time to step up and say E-N-O-U-G-H! One woman suffering from lymphoma due to breast implants is already too many. Contact us today to learn your legal options if you have or had Allergan breast implants.
